Burrill on Biotech - BioPharm International

ADVERTISEMENT

Burrill on Biotech

Pharmaceutical Dealmaking Broadens its Partnering Base

July 1, 2012

Collaborative R&D models coincide with new ways to fund translational research.

A Strong Start to 2012

April 1, 2012

Better news about the global economy buoys life-sciences funding.

Global Economic Woes Overshadow Biotech Industry Advances in 2011

January 1, 2012

Greater emphasis on focus and efficiency for companies as market demands value in 2012.

Volatile Markets Take a Toll on Life-Sciences Initial Public Offerings

October 1, 2011

Volatile Markets Take a Toll on Life-Sciences Initial Public Offerings

Biotech Posts Strong Gains

July 1, 2011

Strong pipelines, approvals, and deals drive up market cap.

Biotech Starts the Year Positively

April 1, 2011

Industry starts the year with a positive spin.

Biotech Writes its New "Play Book"

January 1, 2011

Business models that were used to create current value are no longer going to be effective going forward.

Biotech Cools Off as Capital Markets Weaken

October 1, 2010

Biotech's mid-sized elites position themselves for growth.

Capital Market's Woes Weigh Heavily on Biotech

July 1, 2010

After a bright start to the year, some of biotech's blue chip companies have seen their early gains turn into losses.

ADVERTISEMENT

ADVERTISEMENT

Click here